Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
26th North American IS...26th North American ISSX
Not Confirmed
Not Confirmed
15-18 September, 2024
Not Confirmed
Not Confirmed
16-17 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
26th North American IS...26th North American ISSX
Industry Trade Show
Not Confirmed
15-18 September, 2024
Industry Trade Show
Not Confirmed
16-17 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination
29 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/transcenta-holding-limited-stock-code-6628hk-announce-2024-interim-results-302233808.html
09 Apr 2024
// PHARMABIZ
08 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/transcenta-announces-collaboration-with-agilent-to-develop-a-claudin18-2-companion-diagnostic-to-support-osemitamab-tst001-global-phase-iii-trial-302111036.html
13 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/transcenta-announces-the-publication-of-preclinical-results-of-177lulu-tst001-radionuclide-antibody-conjugate-as-potential-novel-treatment-option-for-metastatic-gastric-cancer-in-the-european-journal-of-nuclear-medicine-and-mole-302013860.html
23 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/transcenta-unveils-updated-efficacy-data-from-osemitamab-tst001-plus-capox-as-first-line-treatment-for-ggej-cancer-study-at-esmo-2023-301964563.html
03 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-grants-transcenta-clearance-to-proceed-with-global-phase-iii-trial-of-osemitamab-tst001-as-first-line-treatment-for-gastricgastroesophageal-cancer-patients-301946033.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?